Search Results - "Wagenmann, M"
-
1
EAACI Position paper on the standardization of nasal allergen challenges
Published in Allergy (Copenhagen) (01-08-2018)“…Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhinitis. In daily clinical routine, experimentally, or when measuring therapeutic…”
Get full text
Journal Article -
2
The EUFOREA pocket guide for chronic rhinosinusitis
Published in Rhinology (01-02-2023)“…Chronic rhinosinusitis (CRS) is known to affect around 5 % of the total population, with major impact on the quality of life of those severely affected (1)…”
Get full text
Journal Article -
3
Complications of anterior skull base surgery
Published in HNO (01-06-2018)“…Anterior skull base operations are complex surgical procedures that are performed to treat serious and complicated diseases. Despite significant advances in…”
Get full text
Journal Article -
4
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP
Published in Rhinology (01-06-2024)“…Severe chronic rhinosinusitis with nasal polyps (CRSwNP), a form of diffuse bilateral (usually type 2) CRS, is a debilitating disease with a significant impact…”
Get full text
Journal Article -
5
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design
Published in American journal of rhinology & allergy (01-11-2022)“…Background Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma are chronic type 2 inflammatory diseases that are frequently associated with each…”
Get full text
Journal Article -
6
Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo
Published in Molecular therapy. Oncolytics (15-09-2022)“…Chimeric antigen receptor (CAR) T cell therapy has demonstrated unprecedented success with high remission rates for heavily pretreated patients with…”
Get full text
Journal Article -
7
Droplet exposure during tracheotomy : Case analysis and consequences with respect to COVID-19 patients
Published in HNO (01-08-2021)“…The COVID(coronavirus disease)-19 pandemic is characterized by high infectivity, droplet transmission, and high viral load in the upper respiratory tract…”
Get full text
Journal Article -
8
Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies
Published in Gene therapy (01-07-2016)“…Engineering autologous or allogeneic T cells to express a suicide gene can control potential toxicity in adoptive T-cell therapies. We recently reported the…”
Get full text
Journal Article -
9
EUFOREA treatment algorithm for allergic rhinitis
Published in Rhinology (2020)Get full text
Journal Article -
10
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement
Published in The World Allergy Organization journal (01-05-2020)“…Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several…”
Get full text
Journal Article -
11
Interdisciplinary surgery to the central skull base-current status
Published in HNO (01-01-2022)“…The skull base is a surgically complex unit and is often only accessible via combined access routes. Newly developed surgical techniques using microsurgical…”
Get full text
Journal Article -
12
Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity
Published in Clinical and experimental allergy (01-10-2013)“…Summary Background Serum levels of IL‐16, IL‐33 and the decoy receptor of IL‐33, soluble ST2, are elevated in allergic rhinitis. Recent studies show that…”
Get full text
Journal Article -
13
Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines
Published in Klinische Padiatrie (01-04-2012)“…Fanconi anemia (FA) is a rare recessive DNA repair disorder that is clinically characterized by congenital malformations, progressive bone marrow failure, and…”
Get more information
Journal Article -
14
The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge
Published in Allergy (Copenhagen) (01-09-2005)“…Background: Late phase reactions after allergen challenge can be understood as a correlate of the inflammatory reaction in allergic rhinitis. Methods: To…”
Get full text
Journal Article -
15
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
Published in Journal of asthma and allergy (01-01-2023)“…Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predominantly type 2 inflammatory disease with a high symptom burden. Data are lacking on the…”
Get full text
Journal Article -
16
Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis
Published in Rhinology (01-08-2011)“…Background: Intranasal corticosteroids (INS) are the first line treatment for allergic rhinitis (AR). To guide clinical decision-making, we created a…”
Get full text
Journal Article -
17
EUFOREA treatment algorithm for allergic rhinitis
Published in Rhinology (01-12-2020)Get full text
Journal Article -
18
IL-5 synthesis is upregulated in human nasal polyp tissue
Published in Journal of allergy and clinical immunology (01-06-1997)“…Background: In most nasal polyps, tissue eosinophilia is a striking finding, the pathologic mechanism of which is not understood. Objective: This study was…”
Get full text
Journal Article -
19
Seasonal and Perennial Allergic Rhinoconjunctivitis
Published in Laryngo- rhino- otologie (01-02-2017)“…Seasonsal allergic conjunctivitis (SAC) and perennial allergic conjunctivitis (PAC) as well as intermittent and persistent allergic rhinitis are widespread…”
Get more information
Journal Article -
20
Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis
Published in Rhinology (01-08-2011)“…Intranasal corticosteroids (INS) are the first line treatment for allergic rhinitis (AR). To guide clinical decision-making, we created a therapeutic index…”
Get full text
Journal Article